

PsychRounds: The Psychiatry Podcast
Dr. Tanner Hewitt, Dr. Larry Wang and Dr. Bradley Miller
Welcome to Psych Rounds, the podcast tailored for psychiatry residents and students. Join us, three psychiatric resident physicians, as we delve into quick insights, interviews, and practical tips essential for educational practice. Subscribe for a straightforward yet informal approach to psychiatric knowledge.
Contact us: psychroundspodcast@gmail.com
Instagram: https://www.instagram.com/psychrounds/
Contact us: psychroundspodcast@gmail.com
Instagram: https://www.instagram.com/psychrounds/
Episodes
Mentioned books

6 snips
Jan 26, 2024 • 14min
[SNRI] - Milnacipran (Savella) & Levomilnacipran (Fetzima)
Dive into the fascinating world of serotonin-norepinephrine reuptake inhibitors, focusing on Fetzima and Savella. Discover their unique properties, including the financial impact on patients and intriguing dosing strategies. The podcast explores their versatile applications in treating depression, anxiety, and neuropathic pain, while also unpacking their pharmacological complexities. A highlight is the discussion on the norepinephrine paradox in psychiatric treatment, emphasizing the need for deeper understanding in mental health therapies.

10 snips
Jan 19, 2024 • 19min
[SNRI] - Duloxetine (Cymbalta)
Dive into the fascinating world of Duloxetine, an SNRI used to tackle depression, anxiety, and chronic pain. Discover its unique properties compared to other medications and learn about dosing strategies and side effects. Gain insights into its clinical uses, including special considerations for children and patients with liver issues. The discussion also sheds light on the importance of medication adherence and how to effectively manage co-existing conditions.

17 snips
Jan 12, 2024 • 31min
[SNRI] - Venlafaxine (Effexor) & Desvenlafaxine (Pristiq)
Dive into the world of SNRIs, focusing on Venlafaxine and Desvenlafaxine. Discover their history, mechanism of action, and unique dosing strategies. The discussion highlights potential side effects, especially the risks to blood pressure at higher doses. Learn about innovative approaches for treatment-resistant depression, such as combining Effexor with mirtazapine. Gain insights into the importance of tailoring prescriptions to individual patient needs, including considerations for adherence and monitoring health factors.

4 snips
Jan 5, 2024 • 29min
[Review] - Question Series #1
Join us for our first review series. We will be discussing several board-style questions based on our previous episodes with special guest, Dr. Bradley Miller.

14 snips
Dec 29, 2023 • 26min
[NaSSA] - Mirtazapine (Remeron)
Discover the fascinating world of mirtazapine, a unique antidepressant with a dual action on noradrenaline and serotonin. Explore its sedative effects, rapid relief for sleep issues, and its controversial 'California rocket fuel' combination. Learn about its pharmacokinetics, minimal interactions, and FDA-approved uses for major depression. The discussion also delves into the benefits for the elderly, such as appetite stimulation, against concerns like weight gain. It highlights ideal candidates for treatment and dispels common misconceptions surrounding this intriguing medication.

15 snips
Dec 22, 2023 • 27min
[NDRI] - Buproprion (Wellbutrin)
Dive into the fascinating world of Bupropion, an NDRI with a rich history as both an antidepressant and smoking cessation aid. Discover its unique effects on neurotransmitters and how it stands out with fewer sexual side effects. The discussion highlights its FDA approvals for seasonal affective disorder and smoking addiction, along with promising off-label uses like treating methamphetamine use disorder. Learn about the potential benefits and risks, including its association with seizures, and why it’s underutilized despite its effectiveness.

8 snips
Dec 16, 2023 • 7min
[SSRI] - Citalopram (Celexa)
Dive into the world of Citalopram as it treats Major Depressive Disorder, especially in older adults. Discover its unique antihistamine effects that may aid the elderly in managing sleep and agitation. Learn about factors influencing its declining popularity, including FDA warnings and the rise of escitalopram as a top choice. Explore the crucial role of the CYP2C19 enzyme in Citalopram's metabolism and its implications for personalized medicine, shedding light on risks of elevated drug concentrations.

19 snips
Dec 6, 2023 • 11min
[SSRI] - Sertraline (Zoloft)
Dive into the world of Zoloft as you explore its uses in treating various mental health conditions. Discover its unique pharmacology and safety profile for geriatric patients. Learn about prescribing considerations during pregnancy and the importance of dosing strategies for effective outcomes. Delve into common side effects, particularly gastrointestinal issues, and understand how these compare to other SSRIs. Finally, uncover the flexibility of Zoloft's dosing range and its benefits for treating atypical depression.

16 snips
Dec 4, 2023 • 12min
[SSRI] - Fluvoxamine (Luvox) & Paroxetine (Paxil)
The discussion dives into the pharmacokinetics of paroxetine, highlighting its short half-life and the challenges of discontinuation syndrome. It explores the calming effects of Paxil, particularly for anxiety disorders, while addressing safety during pregnancy. The role of paroxetine in managing menopause symptoms, like hot flashes, is also examined. Additionally, the unique application of fluvoxamine for OCD treatment is analyzed, comparing its effectiveness and side effects against other SSRIs, and emphasizing dosing strategies for better patient outcomes.

17 snips
Dec 3, 2023 • 6min
[SSRI] - Escitalopram (Lexapro)
Dive into the world of Lexapro, a leading SSRI known for its effectiveness in treating depression and anxiety. Discover its minimal drug interactions and ideal dosing for different age groups, especially in geriatrics. The discussion also highlights off-label uses, particularly for OCD, shedding light on safety concerns for both older adults and children. Personal insights provide a deeper understanding of what makes escitalopram a favored choice among SSRIs.


